- Home
- EYPT vs PLTK Comparison
EYPT vs PLTK Comparison
Compare EYPT & PLTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EYPT | PLTK |
|---|---|---|
| Founded | 1987 | 2010 |
| Country | United States | Israel |
| Employees | N/A | 3175 |
| Industry | Biotechnology: Laboratory Analytical Instruments | EDP Services |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EYPT | PLTK |
|---|---|---|
| Price | $13.36 | $3.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $31.80 | $5.04 |
| AVG Volume (30 Days) | 786.6K | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 11.46% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,539,000.00 | ★ $2,755,400,000.00 |
| Revenue This Year | N/A | $2.60 |
| Revenue Next Year | $3,115.57 | $2.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.08 |
| 52 Week Low | $5.46 | $2.64 |
| 52 Week High | $19.11 | $5.34 |
Technical Indicators
Market Signals| Indicator | EYPT | PLTK |
|---|---|---|
| Relative Strength Index (RSI) | 43.22 | 64.68 |
| Support Level | $12.47 | $3.56 |
| Resistance Level | $13.32 | $3.79 |
| Average True Range (ATR) | 0.63 | 0.14 |
| MACD | -0.11 | 0.01 |
| Stochastic Oscillator | 27.50 | 90.06 |
Price Performance
Historical ComparisonAbout EYPT EyePoint Pharmaceuticals Inc.
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.
About PLTK Playtika Holding Corp.
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. The company offers both Mobile and Web-based platforms.